Plitman Eric, Venkatraghavan Lashmi, Agrawal Sanket, Raghavan Vishvak, Chowdhury Tumul, Sobczyk Olivia, Sayin Ece Su, Poublanc Julien, Duffin James, Mikulis David, Fisher Joseph
Department of Anesthesia and Pain Management, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Department of Computer Science, Faculty of Science, McGill University, Montreal, Quebec, Canada.
Asian J Neurosurg. 2024 Jun 6;19(2):235-241. doi: 10.1055/s-0044-1786699. eCollection 2024 Jun.
Controlling the partial pressure of carbon dioxide (PaCO ) is an important consideration in patients with intracranial steno-occlusive disease to avoid reductions in critical perfusion from vasoconstriction due to hypocapnia, or reductions in blood flow due to steal physiology during hypercapnia. However, the normal range for resting PCO in this patient population is not known. Therefore, we investigated the variability in resting end-tidal PCO (P CO ) in patients with intracranial steno-occlusive disease and the impact of revascularization on resting P CO in these patients. Tertiary care center, retrospective chart review We collected resting P CO values in adult patients with intracranial steno-occlusive disease who presented to our institution between January 2010 and June 2021. We also explored postrevascularization changes in resting P CO in a subset of patients. Two hundred and twenty-seven patients were included [moyamoya vasculopathy ( = 98) and intracranial atherosclerotic disease ( = 129)]. In the whole cohort, mean ± standard deviation resting P CO was 37.8 ± 3.9 mm Hg (range: 26-47). In patients with moyamoya vasculopathy and intracranial atherosclerotic disease, resting P CO was 38.4 ± 3.6 mm Hg (range: 28-47) and 37.4 ± 4.1 mm Hg (range: 26-46), respectively. A trend was identified suggesting increasing resting P CO after revascularization in patients with low preoperative resting P CO (<38 mm Hg) and decreasing resting P CO after revascularization in patients with high preoperative resting P CO (>38 mm Hg). This study demonstrates that resting P CO in patients with intracranial steno-occlusive disease is highly variable. In some patients, there was a change in resting P CO after a revascularization procedure.
对于患有颅内狭窄闭塞性疾病的患者,控制二氧化碳分压(PaCO₂)是一个重要的考量因素,以避免因低碳酸血症导致血管收缩引起的关键灌注减少,或因高碳酸血症期间盗血生理导致的血流减少。然而,该患者群体静息PCO₂的正常范围尚不清楚。因此,我们调查了颅内狭窄闭塞性疾病患者静息呼气末PCO₂(PetCO₂)的变异性以及血运重建对这些患者静息PetCO₂的影响。
三级医疗中心,回顾性病历审查
我们收集了2010年1月至2021年6月期间到我院就诊的成年颅内狭窄闭塞性疾病患者的静息PetCO₂值。我们还探讨了一部分患者血运重建后静息PetCO₂的变化。
纳入了227例患者[烟雾病(n = 98)和颅内动脉粥样硬化疾病(n = 129)]。在整个队列中,静息PetCO₂的平均值±标准差为37.8±3.9 mmHg(范围:26 - 47)。在烟雾病和颅内动脉粥样硬化疾病患者中,静息PetCO₂分别为38.4±3.6 mmHg(范围:28 - 47)和37.4±4.1 mmHg(范围:26 - 46)。发现一种趋势,即术前静息PetCO₂低(<38 mmHg)的患者血运重建后静息PetCO₂升高,而术前静息PetCO₂高(>38 mmHg)的患者血运重建后静息PetCO₂降低。
本研究表明,颅内狭窄闭塞性疾病患者的静息PetCO₂高度可变。在一些患者中,血运重建术后静息PetCO₂发生了变化。